Full Text View
Tabular View
Study Results
Related Studies
Safety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa (EB)
This study has been terminated.
( Insufficient patient enrollment )
Study NCT00587223   Information provided by Organogenesis

First Received on December 21, 2007.   Last Updated on June 25, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Epidermolysis Bullosa, Junctional
Epidermolysis Bullosa Dystrophica
Additional conditions recognized in this trial
Epidermolysis Bullosa
More general conditions related to this trial
Collagen Diseases
Congenital Abnormalities
Connective Tissue Diseases
Genetic Diseases, Inborn
Skin Abnormalities
Skin Diseases
Skin Diseases, Genetic
Skin Diseases, Vesiculobullous
Interventions listed in this trial
Apligraf
Standard dressing regimen
Sponsors listed in this trial
Organogenesis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services